Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

UWMC Stock: Can r/WallStreetBets Send RKT Rival UWM to the Moon?

By Robert Lakin, InvestorPlace Contributor

Fresh from a SPAC merger, UWMC stock is set for another day of double-digit gains. Is the surge the work of Redditors or a bet on lower interest rates stoking the mortgage market?

KMPH Stock: The Big News That Has KemPharm Soaring Today

By Robert Lakin, InvestorPlace Contributor

KemPharm's prodrug development platform got a huge boost from the FDA's new drug application nod for an ADHD treatment.

CFMS Stock: Why Under-the-Radar Conformis Is on the Move

By Robert Lakin, InvestorPlace Contributor

CFMS stock is jumping as Conformis preps to introduce a knee replacement system in Australia. Here's what you should know.

RKT Stock: 3 Big Reasons Rocket Shares Are Gaining Today

By Robert Lakin, InvestorPlace Contributor

RKT stock is on the move Tuesday thanks to easing Treasury yields and a lot of hype from r/WallStreetBets. Here's what to know.

HOL Stock: Why Red-Hot Space Play Holicity Is Soaring Today

By Robert Lakin, InvestorPlace Contributor

HOL stock is on the move today after space SPAC partner Astra landed an $8 million contract with NASA. Here's what to know.

Load More